Steve Pakola insider trades
Steve Pakola has filed 15 Form 4s with the SEC that we hold, all for REGENXBIO Inc. (RGNX), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 9 sales worth $1.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($940.0K). The largest single trade was a sale of 36,725 shares of REGENXBIO Inc. worth $472.3K, dated 2026-07-01. The first filing on our record is dated 2022-01-04 and the latest 2026-08-04.
REGENXBIO Inc. (RGNX)
Chief Medical Officer · 15 filings · 9 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-01-03 | S, sale reported on Form 4 | 1,598 | $53.9K | 2022-01-04 | SEC |
| 2023-01-03 | S, sale reported on Form 4 | 3,138 | $69.6K | 2023-01-05 | SEC |
| 2024-01-03 | S, sale reported on Form 4 | 17,237 | $299.8K | 2024-01-04 | SEC |
| 2024-03-05 | S, sale reported on Form 4 | 12,878 | $365.2K | 2024-03-07 | SEC |
| 2026-03-10 | S, sale reported on Form 4 | 5,124 | $53.0K | 2026-03-12 | SEC |
| 2026-05-11 | S, sale reported on Form 4 | 15,309 | $168.7K | 2026-05-13 | SEC |
| 2026-06-29 | S, sale reported on Form 4 | 19,608 | $216.5K | 2026-07-01 | SEC |
| 2026-07-01 | S, sale reported on Form 4 | 36,725 | $472.3K | 2026-07-01 | SEC |
| 2026-07-02 | S, sale reported on Form 4 | 2,161 | $29.5K | 2026-07-06 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1700659) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
